on-line self-management training for Parkinson's (NCT06248073)
Increase participation in daily activities
- Trial ID
- NCT06248073
- Official Title
- Comparing the Effectiveness of Online Self-management Program and On-site Task-related Training for People With Early Stage Parkinson's Disease on Activity Participation and Quality of Life
- Goal
- Increase participation in daily activities
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Chang Gung University
- Study Type
- INTERVENTIONAL
- Enrollment
- 100 participants
- Conditions
- Parkinson Disease, Occupational Therapy, Telerehabilitation, Activities of Daily Living
- Interventions
- on-line self-management training, onsite task-related training
Summary For Families
The goal is to see whether an online self-management program or hands-on task-related training better improves participation in daily activities and quality of life for people with early, mild Parkinson's. The online program teaches self-management skills, goal-setting and guided home exercises to help people adapt and practice daily tasks remotely, while the on-site task training gives supervised practice of reaching and other functional movements to retrain coordination and confidence; both approaches aim to boost real-world function and are meant to complement, not replace, medications like levodopa. The trial is looking for people aged 45 to 70 with mild idiopathic Parkinson's, Hoehn and Yahr stage 1,2, who have no cognitive impairment or severe depression, no major sensory or upper-limb problems or severe tremor, and who have not had physical or occupational therapy in the past year.
Locations
- Chang Gung Memorial Hospital, Linkou District, Taiwan
Frequently Asked Questions
- What is this trial testing?
- This trial is studying on-line self-management training. The goal is to see whether an online self-management program or hands-on task-related training better improves participation in daily activities and quality of life for people with early, mild Parkinson's. The online program teaches self-management skills, goal-setting and guided home exercises to help people adapt and practice daily tasks remotely, while the on-site task training gives supervised practice of reaching and other functional movements to retrain coordination and confidence; both approaches aim to boost real-world function and are meant to complement, not replace, medications like levodopa. The trial is looking for people aged 45 to 70 with mild idiopathic Parkinson's, Hoehn and Yahr stage 1,2, who have no cognitive impairment or severe depression, no major sensory or upper-limb problems or severe tremor, and who have not had physical or occupational therapy in the past year.
- Who can participate?
- Participants must be between 45 Years and 70 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 3 years and 5 months.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- This trial has a group that receives no study treatment (you would continue your usual care) alongside the treatment groups. Because assignment is random, you have about a 1 in 3 chance (roughly 33%) of being in the no-treatment group, assuming the groups are filled equally. Ask the coordinator to confirm the exact assignment ratio.